Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1185246

Recurrent Venous Thrombosis Despite ‘Optimal Anticoagulation Therapy’ for Antiphospholipid Syndrome – Could New Oral Anticoagulants Solve the Problem?


Balaban, Manuela; Stančić, Vladimir; Rinčić, Goran; Ledinsky, Mario; Lang, Nada; Grbac, Ljiljana; Stančić, Nevenka; Tomašić, Hrvoje
Recurrent Venous Thrombosis Despite ‘Optimal Anticoagulation Therapy’ for Antiphospholipid Syndrome – Could New Oral Anticoagulants Solve the Problem? // Acta clinica Croatica, 49 (2010), 4; 469-477 (recenziran, ostalo, znanstveni)


CROSBI ID: 1185246 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Recurrent Venous Thrombosis Despite ‘Optimal Anticoagulation Therapy’ for Antiphospholipid Syndrome – Could New Oral Anticoagulants Solve the Problem?

Autori
Balaban, Manuela ; Stančić, Vladimir ; Rinčić, Goran ; Ledinsky, Mario ; Lang, Nada ; Grbac, Ljiljana ; Stančić, Nevenka ; Tomašić, Hrvoje

Izvornik
Acta clinica Croatica (1333-9451) 49 (2010), 4; 469-477

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, ostalo, znanstveni

Ključne riječi
Antiphospholipid syndrome – complications ; Antiphospholipid syndrome – drug therapy ; Thrombosis – etiology ; Thrombosis – prevention and control ; Warfarin – therapeutic use ; Case report

Sažetak
The aim was to determine the validity of the international normalized ratio (IN R) and prothrombin time (PT ) as a monitor for warfarin therapy in patients with lupus anticoagulants and recurrent thrombosis, and to investigate alternative approaches to monitoring warfarin therapy and new treatment options in these patients. A case is described of a 63-year-old female with antiphospholipid syndrome and recurrent venous thrombosis despite optimal adjusted warfarin therapy. In patients with lupus anticoagulants, the IN Rs obtained while receiving warfarin vary and often overestimate the extent of anticoagulation, while PT without receiving warfarin is often prolonged. In conclusion, lupus anticoagulants can influence PT and lead to IN R that does not accurately reflect the true level of anticoagulation. Optimizing of (warfarin) oral anticoagulation therapy could be achieved by individual monitoring of anticoagulation effect with a test that is insensitive to lupus anticoagulants (chromogenic factor X assay). Emerging oral anticoagulants, direct thrombin inhibitors and direct factor Xa inhibitors, such as dabigatran and rivaroxaban, with a predictable anticoagulant response and little potential for food or drug interactions, have been designed to be administered in fixed doses without coagulation monitoring and could be the treatment choice for these patients.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Profili:

Avatar Url Goran Rinčić (autor)

Avatar Url Vladimir Stančić (autor)

Avatar Url Nada Lang (autor)

Avatar Url Mario Ledinsky (autor)

Avatar Url Manuela Balaban (autor)

Citiraj ovu publikaciju:

Balaban, Manuela; Stančić, Vladimir; Rinčić, Goran; Ledinsky, Mario; Lang, Nada; Grbac, Ljiljana; Stančić, Nevenka; Tomašić, Hrvoje
Recurrent Venous Thrombosis Despite ‘Optimal Anticoagulation Therapy’ for Antiphospholipid Syndrome – Could New Oral Anticoagulants Solve the Problem? // Acta clinica Croatica, 49 (2010), 4; 469-477 (recenziran, ostalo, znanstveni)
Balaban, M., Stančić, V., Rinčić, G., Ledinsky, M., Lang, N., Grbac, L., Stančić, N. & Tomašić, H. (2010) Recurrent Venous Thrombosis Despite ‘Optimal Anticoagulation Therapy’ for Antiphospholipid Syndrome – Could New Oral Anticoagulants Solve the Problem?. Acta clinica Croatica, 49 (4), 469-477.
@article{article, author = {Balaban, Manuela and Stan\v{c}i\'{c}, Vladimir and Rin\v{c}i\'{c}, Goran and Ledinsky, Mario and Lang, Nada and Grbac, Ljiljana and Stan\v{c}i\'{c}, Nevenka and Toma\v{s}i\'{c}, Hrvoje}, year = {2010}, pages = {469-477}, keywords = {Antiphospholipid syndrome – complications, Antiphospholipid syndrome – drug therapy, Thrombosis – etiology, Thrombosis – prevention and control, Warfarin – therapeutic use, Case report}, journal = {Acta clinica Croatica}, volume = {49}, number = {4}, issn = {1333-9451}, title = {Recurrent Venous Thrombosis Despite ‘Optimal Anticoagulation Therapy’ for Antiphospholipid Syndrome – Could New Oral Anticoagulants Solve the Problem?}, keyword = {Antiphospholipid syndrome – complications, Antiphospholipid syndrome – drug therapy, Thrombosis – etiology, Thrombosis – prevention and control, Warfarin – therapeutic use, Case report} }
@article{article, author = {Balaban, Manuela and Stan\v{c}i\'{c}, Vladimir and Rin\v{c}i\'{c}, Goran and Ledinsky, Mario and Lang, Nada and Grbac, Ljiljana and Stan\v{c}i\'{c}, Nevenka and Toma\v{s}i\'{c}, Hrvoje}, year = {2010}, pages = {469-477}, keywords = {Antiphospholipid syndrome – complications, Antiphospholipid syndrome – drug therapy, Thrombosis – etiology, Thrombosis – prevention and control, Warfarin – therapeutic use, Case report}, journal = {Acta clinica Croatica}, volume = {49}, number = {4}, issn = {1333-9451}, title = {Recurrent Venous Thrombosis Despite ‘Optimal Anticoagulation Therapy’ for Antiphospholipid Syndrome – Could New Oral Anticoagulants Solve the Problem?}, keyword = {Antiphospholipid syndrome – complications, Antiphospholipid syndrome – drug therapy, Thrombosis – etiology, Thrombosis – prevention and control, Warfarin – therapeutic use, Case report} }

Časopis indeksira:


  • Scopus
  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font